Among the more than 15 phosphorylation sites identified in the CPTAC dataset, five sites—S167, S171, S174, S190, and S194—exhibited increased phosphorylation levels, even after normalization to total NAA10 protein abundance, in several tumor types, including breast and lung cancers. This evidence concerns the gene NAA10 and lung carcinoma.